SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001144204-14-036135
Filing Date
2014-06-06
Accepted
2014-06-06 15:09:05
Documents
7
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 10-Q v378706_10qa.htm 10-Q/A 20769
  Complete submission text file 0001144204-14-036135.txt   2603247

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE DOCUMENT ck0001582554-20140331.xml EX-101.INS 325568
3 XBRL TAXONOMY EXTENSION SCHEMA ck0001582554-20140331.xsd EX-101.SCH 39776
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ck0001582554-20140331_cal.xml EX-101.CAL 26473
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ck0001582554-20140331_def.xml EX-101.DEF 190636
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE ck0001582554-20140331_lab.xml EX-101.LAB 201134
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ck0001582554-20140331_pre.xml EX-101.PRE 219830
Mailing Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921
Business Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921 908-443-1860
Matinas BioPharma Holdings, Inc. (Filer) CIK: 0001582554 (see all company filings)

IRS No.: 463011414 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 333-193455 | Film No.: 14896371
SIC: 2834 Pharmaceutical Preparations